Understanding Laryngeal Tumours: Types, Classification, and Pathology
Laryngeal tumours can be benign or malignant, with different types such as papilloma, chondroma, paraganglioma, and squamous cell carcinoma. These tumours present with various symptoms and may spread through direct, lymphatic, or hematogenous routes. Risk factors include tobacco smoking, alcohol con
0 views • 24 slides
Overview of Bladder Tumours: Causes, Symptoms, and Diagnosis
Bladder tumours, particularly Transitional Cell Carcinoma (TCC), are the second most common cancer in the genitourinary system. Mainly caused by factors like cigarette smoking, industrial toxins, and genetic events, bladder cancer presents with symptoms such as hematuria and irritative voiding sympt
0 views • 26 slides
Excised Biopsy Tract Histology for Primary Bone Tumours: Necessity of Excision Examined
Investigating the necessity of excising biopsy tracts in primary bone tumours, this study analyzed 278 patients over a span of two years. Findings indicated conflicting evidence regarding the risk of malignant seeding in biopsy tracts, with only one patient showing histological evidence of seeding.
0 views • 14 slides
Comprehensive Guide to Peptide Receptor Radionuclide Therapy (PRRNT) in Neuroendocrine Tumours (NET)
Peptide Receptor Radionuclide Therapy (PRRNT) is a targeted approach using radiopharmaceuticals to deliver radiation to neuroendocrine tumors expressing specific receptors. This therapy, involving 90Y-DOTATOC or 177Lu-DOTATATE, has shown promising results in treating NETs with minimal side effects.
0 views • 36 slides
Advances in Neuroendocrine Tumours: ESMO 2019 Update
Update from the ESMO 2019 meeting in Barcelona focusing on neuroendocrine tumors (NETs). Highlighting challenges in diagnosis and treatment, including limited knowledge and late diagnosis. Discusses different types of NETs, prevalence, approved therapeutic options, and key trials presented at the co
0 views • 20 slides